Clinical Trial Update: Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing transarterial chemoembolization with stereotactic body radiation therapy or stereotactic ablative radiation therapy for residual or re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Stereotactic Body Radiation Therapy (SBRT)
• Transarterial chemoembolization (chemotherapy with embolization (various agents))
• stereotactic ablative radiation therapy (stereotactic ablative radiation therapy)

Snippet

Sponsor: Stanford University | Conditions: Child-Pugh Class A, Child-Pugh Class B | Phase 3 | Status: TERMINATED | Results posted: 2024-03-12